Recombinant FIX concentrates are currently used to prevent and treat bleeding in patients with hemophilia B, an X-linked bleeding disorder caused by FIX deficiency (Rocca et al., 2011; EMA et al., 2021a, 2021b, 2021c, 2021d). This evidence concerns the gene F9 and hemophilia B.